US-guided diffused optical tomography: a promising functional imaging technique in breast lesions.
OBJECTIVE
To investigate the feasibility and clinical efficacy of ultrasound (US)-guided diffused optical tomography (DOT) in differentiating malignant breast lesions from benign lesions.


METHODS
From October 2007 to August 2008, 198 women with 214 lesions scheduled for open biopsy were included in this study. Conventional US was used to locate the breast lesion, and DOT to measure the total haemoglobin concentration (THC) for each breast lesion. Sensitivity, specificity and overall accuracy were determined with surgical pathology as the gold standard.


RESULTS
There were 96 benign lesions and 118 malignant lesions. The total haemoglobin concentration (THC) of all 214 lesions was calculated from DOT. The average THC in benign lesions was 125.5 +/- 83.4 micromol/L, and in malignant lesions 222.2 +/- 87.2 micromol/L. The THC of malignant lesions was significantly higher than that of benign lesions (p < 0.05). When a THC of 140 micromol/L was used as the cutoff value for differentiating breast cancer from benign lesions, the sensitivity, specificity, accuracy, positive predictive value and negative predictive value of DOT were 83.9%, 66.7%, 76.2%, 75.6% and 77.1%, respectively. Our study demonstrated that THC was significantly higher in malignant lesions than in benign lesions.


CONCLUSIONS
US-guided diffused optical tomography, a noninvasive functional imaging technique, has potential utility in differentiating breast cancer from benign lesions.
You
Shan-Shan
SS
Department of Diagnostic Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, Wangfujing, Beijing 100730, China.
Jiang
Yu-Xin
YX
Zhu
Qing-Li
QL
Liu
Ji-Bin
JB
Zhang
Jing
J
Dai
Qing
Q
Liu
He
H
Sun
Qiang
Q
D000293:Adolescent; D000328:Adult; D000368:Aged; D001707:Biopsy, Needle / Q000379:methods*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D025321:Surgery, Computer-Assisted / Q000379:methods*; D041622:Tomography, Optical / Q000379:methods*; D016217:Ultrasonography, Mammary / Q000379:methods*; D055815:Young Adult
J Biomed Opt. 2004 May-Jun;9(3):504-10
15189088
Technol Cancer Res Treat. 2005 Oct;4(5):513-26
16173822
Appl Opt. 2004 Mar 10;43(8):1654-62
15046168
Neoplasia. 2003 Sep-Oct;5(5):379-88
14670175
Arthritis Res. 2001;3(3):147-53
11299055
Radiology. 2005 Oct;237(1):57-66
16183924
N Engl J Med. 1991 Jan 3;324(1):1-8
1701519
Am Surg. 1986 Mar;52(3):123-8
3954258
Appl Opt. 2001 Jul 1;40(19):3288-303
11958271
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8828-33
16731633
Eur Radiol. 1997;7(8):1231-4
9377507
Cancer Imaging. 2007 Feb 28;7:34-40
17339139
J Nucl Med. 2002 Apr;43(4):500-9
11937594
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12349-54
14514888
Technol Cancer Res Treat. 2005 Jun;4(3):235-44
15896078
Appl Opt. 2003 Jul 1;42(19):4102-14
12868853
EXS. 1997;79:11-28
9002218
Breast Cancer Res. 2001;3(1):41-6
11250744
Breast Cancer Res Treat. 2008 Mar;108(1):9-22
17468951
Conf Proc IEEE Eng Med Biol Soc. 2005;2006:278-81
17282167
N Engl J Med. 1971 Nov 18;285(21):1182-6
4938153
Int J Radiat Biol. 1991 Jul-Aug;60(1-2):85-100
1678003
Neoplasia. 2005 Mar;7(3):263-70
15799826
Photochem Photobiol. 1998 Jan;67(1):4-14
9477760
Rheumatology (Oxford). 1999 Feb;38(2):103-12
10342621